Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

Lymphatic metastasis is a major determinant of the outcome of resected pancreatic cancer. Gemcitabine-based adjuvant chemotherapy can improve the outcome of resected pancreatic cancer. However, the efficacy of gemcitabine against pancreatic cancer stratified by nodal involvement is unclear. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chen, Cheng, He, Jin, Kaizhou, Fan, Zhiyao, Gong, Yitao, Qian, Yunzhen, Deng, Shengming, Huang, Qiuyi, Ni, Quanxing, Yu, Xianjun, Luo, Guopei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153189/
https://www.ncbi.nlm.nih.gov/pubmed/32268796
http://dx.doi.org/10.1177/1073274820915947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153189/
https://www.ncbi.nlm.nih.gov/pubmed/32268796
http://dx.doi.org/10.1177/1073274820915947

Ejemplares similares